Intranasal administration of LHRH polypeptides in powdered form

US6521597B1 · kind B1 · utility

Assignee

• Pharmacia Corporation · SE

Inventors

• Brian H. Vickery · Cupertino, US
• Eric Benjamin · Pomona, US
• Cherng-Chyi Fu · Saratoga, US
• Lynda M. Sanders · Palo Alto, US

Key dates

• Filing date: Jun 19, 1992
• Grant date: Feb 18, 2003
• Expiry date: Jun 19, 2012

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/36
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.